Related Experiment Video
Updated: Mar 18, 2026

Manipulation of Ploidy in Caenorhabditis elegans
Published on: March 15, 2018
Epigenetic silencing of serine protease HTRA1 drives polyploidy
Nina Schmidt1, Inga Irle1, Kamilla Ripkens1
1Centre for Medical Biotechnology, Faculty of Biology and Geography, University Duisburg-Essen, Universitaetsstrasse, D-45117, Essen, Germany.
Background:
Increased numbers and improperly positioned centrosomes, aneuploidy or polyploidy, and chromosomal instability are frequently observed characteristics of cancer cells. While some aspects of these events and the checkpoint mechanisms are well studied, not all players have yet been identified. As the role of proteases other than the proteasome in tumorigenesis is an insufficiently addressed question, we investigated the epigenetic control of the widely conserved protease HTRA1 and the phenotypes of deregulation.
Methods:
Mouse embryonal fibroblasts and HCT116 and SW480 cells were used to study the mechanism of epigenetic silencing of HTRA1. In addition, using cell biological and genetic methods, the phenotypes of downregulation of HTRA1 expression were investigated.
Results:
HTRA1 is epigenetically silenced in HCT116 colon carcinoma cells via the epigenetic adaptor protein MBD2. On the cellular level, HTRA1 depletion causes multiple phenotypes including acceleration of cell growth, centrosome amplification and polyploidy in SW480 colon adenocarcinoma cells as well as in primary mouse embryonic fibroblasts (MEFs).
Conclusions:
Downregulation of HTRA1 causes a number of phenotypes that are hallmarks of cancer cells suggesting that the methylation state of the HtrA1 promoter may be used as a biomarker for tumour cells or cells at risk of transformation.
Insights
The protease HTRA1 is epigenetically silenced in cancer cells by MBD2. Its downregulation accelerates cell growth and causes centrosome amplification and polyploidy, hallmarks of cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Epigenetics
Background:
- Cancer cells exhibit increased centrosomes, aneuploidy, polyploidy, and chromosomal instability.
- Checkpoint mechanisms are partially understood, but not all contributing factors are identified.
- The role of proteases beyond the proteasome in tumorigenesis requires further investigation.
Purpose of the Study:
- To investigate the epigenetic control of the protease HTRA1.
- To examine the cellular phenotypes associated with HTRA1 deregulation.
Main Methods:
- Studied epigenetic silencing of HTRA1 in mouse embryonal fibroblasts and HCT116 and SW480 cells.
- Employed cell biological and genetic methods to investigate HTRA1 downregulation phenotypes.
Main Results:
- HTRA1 is epigenetically silenced in HCT116 colon carcinoma cells through the MBD2 protein.
- HTRA1 depletion leads to accelerated cell growth, centrosome amplification, and polyploidy in SW480 cells and primary mouse embryonic fibroblasts (MEFs).
Conclusions:
- HTRA1 downregulation induces phenotypes characteristic of cancer cells.
- The methylation status of the HtrA1 promoter could serve as a biomarker for tumor cells or those at risk of transformation.
Related Concept Videos
piRNA - Piwi-interacting RNAs
Position-effect Variegation
Nondisjunction
Nondisjunction
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

